IGFBP-1 and IGFBP-3 genes expression, as well as their serum levels, were significantly higher in CML patients, whereas IGFBP-2 gene expression was not. Here, IGFBP2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.